Website & contact details
- Website
T-Cypher Bio Limited
- Incorporated
- 27 October 2015 (11 years)
- Previously known as
- Orbit Discovery Ltd (until 9 November 2020)This list may be incomplete. See all names on Companies House
- Industry
- Research and experimental development on biotechnology (72110) Other professional, scientific and technical activities n.e.c. (74909)
- Directors
- Owen Hughes
- Owned by
- Accounts type
- Small
- Region
- South East
- Address
- Barton House Unit 12The QuadrantAbingdonOX14 3YS
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 9 November 2027
- Last conf. stmt
- 26 October 2026
Officers 4 active
Officer details are public data from the Companies House register.
British
Born June 1965 (61)
Director · Appointed 22 June 2026
British
Born January 1982 (44)
Hughes, Owen
Director · Appointed 1 November 2024
American
Born September 1974 (52)
Director · Appointed 25 August 2021
Also at T-Cypher Bio Holdings Limited · more companies
British
Born May 1971 (55)
Officer history (13 former)
22 June 2026
22 June 2026
15 March 2026
9 February 2026
1 November 2024
Appointed Hughes, Owen as Director
9 February 2024
29 June 2023
29 June 2023
29 June 2023
Resigned Ferneau, Philip James as Director
4 January 2023
25 August 2021
25 August 2021
2 August 2021
6 November 2020
6 November 2020
19 October 2020
6 October 2020
1 September 2020
1 June 2020
10 December 2019
1 September 2019
19 April 2018
19 April 2018
19 April 2018
Appointed Ferneau, Philip James as Director
17 May 2016
30 November 2015
30 November 2015
30 November 2015
30 November 2015
27 October 2015
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 18 November 2020
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Limited Company
Reg. no. 12845441
Former controllers (1)
18 November 2020
Ceased Oxford Sciences Innovation PLC — Owns 25–50% of shares
Financials
Balance sheet as at 31 December 2025 · small accounts
- Net Assets
- (£21,613,340)
- Cash
- £5,201,966
- Debt Ratio
- 374%
- Current Ratio
- 6.6x
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £601,662 | £761,705 | £730,129 | £685,650 | £716,821 | £2,680,078 |
| Current Assets | £7,291,950 | £13,640,500 | £7,140,199 | £2,521,396 | £3,153,826 | £1,971,922 |
| Debtors | £2,089,984 | £1,765,641 | £1,282,010 | £1,231,539 | £756,762 | £1,022,449 |
| Cash | £5,201,966 | £11,874,859 | £5,858,189 | £1,289,857 | £2,397,064 | £949,473 |
| Creditors (< 1 year) | £1,100,595 | £1,180,506 | £858,368 | £8,617,549 | £6,024,866 | £256,732 |
| Creditors (> 1 year) | £28,406,357 | £28,413,292 | £16,821,296 | £17,336 | £98,196 | |
| Net Current Assets | £6,191,355 | £12,459,994 | £6,281,831 | (£6,096,153) | (£2,871,040) | £1,715,190 |
| Net Assets | (£21,613,340) | (£15,191,593) | (£9,809,336) | (£5,427,839) | (£2,252,415) | £4,395,268 |
| Shareholder Funds | (£21,613,340) | (£15,191,593) | (£9,809,336) | (£5,427,839) | (£2,252,415) | £4,395,268 |
What T-Cypher Bio say about themselves
“At T-Cypher, we develop drugs against novel disease-specific targets to improve the lives of patients with cancer and autoimmune diseases.”
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 2 November 2026 | Confirmation statement with no updates | 26 October 2026 |
Some other companies at this address
Other companies in this industry
Sandwich
Newcastle Upon Tyne
Edinburgh
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →